The HALT Polycystic Kidney Disease Trials – Analysis of baseline parameters

HALT-PKD consists of two randomized trials comparing treatment with an angiotensin converting inhibitor (ACEI)-angiotensin receptor blocker (ARB) combination vs ACEI alone and standard vs low blood pressure target in Study A (eGFR >60 ml/min/1.73 m(2)) and ACEI-ARB vs ACEI alone in Study B (eGFR...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Torres, Vicente E., Chapman, Arlene B., Perrone, Ronald D., Bae, K. Ty, Abebe, Kaleab Z., Bost, James E., Miskulin, Dana C., Steinman, Theodore I., Braun, William, Winklhofer, Franz T., Hogan, Marie C., Oskoui, Frederic Rahbari, Kelleher, Cass, Masoumi, Amirali, Glockner, James, Halin, Neil J, Martin, Diego, Remer, Erick, Patel, Nayana., Pedrosa, Ivan, Wetzel, Louis H., Thompson, Paul A., Miller, J. Philip, Meyers, Catherine M., Schrier, Robert W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3580956/
https://ncbi.nlm.nih.gov/pubmed/22205355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2011.411
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller